Timber Creek Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.6M Sell
12,631
-14
-0.1% -$14.2K 2.82% 12
2025
Q4
$13.6M Hold
12,645
3.16% 11
2025
Q3
$9.65M Sell
12,645
-32
-0.3% -$23.8K 2.33% 12
2025
Q2
$9.71M Sell
12,677
-71
-0.6% -$55.2K 2.47% 12
2025
Q1
$10.5M Buy
12,748
+31
+0.2% +$25.8K 2.81% 9
2024
Q4
$9.82M Buy
12,717
+85
+0.7% +$70.4K 2.83% 10
2024
Q3
$11.2M Buy
12,632
+86
+0.7% +$77.3K 3.13% 9
2024
Q2
$11.4M Sell
12,546
-12
-0.1% -$9.6K 3.43% 7
2024
Q1
$9.77M Sell
12,558
-2,041
-14% -$1.45M 3.05% 9
2023
Q4
$8.51M Sell
14,599
-738
-5% -$431K 2.9% 9
2023
Q3
$8.24M Sell
15,337
-585
-4% -$301K 2.98% 9
2023
Q2
$7.47M Sell
15,922
-3,748
-19% -$1.57M 2.57% 9
2023
Q1
$6.76M Sell
19,670
-31
-0.2% -$10.5K 2.41% 9
2022
Q4
$7.21M Sell
19,701
-995
-5% -$353K 2.73% 9
2022
Q3
$6.69M Sell
20,696
-259
-1% -$82.1K 2.65% 10
2022
Q2
$6.79M Sell
20,955
-758
-3% -$228K 2.25% 11
2022
Q1
$6.22M Sell
21,713
-2,502
-10% -$644K 1.88% 22
2021
Q4
$6.69M Sell
24,215
-45
-0.2% -$11.4K 1.99% 19
2021
Q3
$5.61M Sell
24,260
-399
-2% -$98.5K 1.78% 26
2021
Q2
$5.66M Buy
24,659
+4,067
+20% +$817K 1.84% 25
2021
Q1
$3.85M Sell
20,592
-2,063
-9% -$404K 1.48% 29
2020
Q4
$3.83M Sell
22,655
-365
-2% -$54.5K 1.7% 23
2020
Q3
$3.41M Buy
23,020
+60
+0.3% +$9.29K 1.87% 21
2020
Q2
$3.77M Sell
22,960
-650
-3% -$99.8K 2.36% 15
2020
Q1
$3.27M Sell
23,610
-8,617
-27% -$1.18M 2.39% 13
2019
Q4
$4.24M Sell
32,227
-1,568
-5% -$182K 2.54% 12
2019
Q3
$3.78M Sell
33,795
-595
-2% -$66.2K 2.42% 12
2019
Q2
$3.81M Sell
34,390
-21
-0.1% -$2.47K 2.46% 12
2019
Q1
$4.46M Sell
34,411
-12,095
-26% -$1.47M 3.01% 10
2018
Q4
$5.38M Sell
46,506
-11,785
-20% -$1.32M 4.19% 5
2018
Q3
$6.25M Sell
58,291
-355
-0.6% -$35.5K 4.03% 6
2018
Q2
$5M Sell
58,646
-1,085
-2% -$89.1K 3.26% 8
2018
Q1
$4.62M Buy
59,731
+230
+0.4% +$18.5K 2.92% 9
2017
Q4
$5.03M Buy
59,501
+1,557
+3% +$132K 3.14% 8
2017
Q3
$4.96M Buy
57,944
+210
+0.4% +$17.2K 3.34% 5
2017
Q2
$4.75M Buy
57,734
+1,123
+2% +$91.6K 3.27% 5
2017
Q1
$4.76M Buy
56,611
+390
+0.7% +$31.2K 3.58% 6
2016
Q4
$4.13M Buy
56,221
+8,229
+17% +$613K 3.22% 6
2016
Q3
$3.85M Buy
47,992
+1,070
+2% +$85.6K 3.09% 7
2016
Q2
$3.69M Buy
46,922
+200
+0.4% +$15.1K 3.09% 6
2016
Q1
$3.36M Sell
46,722
-3,495
-7% -$264K 3.02% 9
2015
Q4
$4.23M Sell
50,217
-2,525
-5% -$210K 3.8% 6
2015
Q3
$4.41M Sell
52,742
-2,120
-4% -$179K 4.13% 6
2015
Q2
$4.58M Sell
54,862
-410
-0.7% -$31.2K 3.73% 6
2015
Q1
$4.01M Sell
55,272
-3,846
-7% -$274K 3.19% 8
2014
Q4
$4.08M Sell
59,118
-16,314
-22% -$1.1M 3.18% 8
2014
Q3
$4.89M Sell
75,432
-9,500
-11% -$601K 4.1% 4
2014
Q2
$5.28M Buy
84,932
+1,680
+2% +$100K 4.4% 4
2014
Q1
$4.9M Buy
83,252
+1,381
+2% +$77.1K 4.45% 3
2013
Q4
$4.17M Buy
81,871
+11,600
+17% +$581K 3.89% 8
2013
Q3
$3.54M Buy
70,271
+840
+1% +$44K 3.24% 15
2013
Q2
$3.41M Buy
+69,431
New +$3.78M 3.16% 18

Other funds holding LLY

Timber Creek Capital Management's LLY Position: Q1 2026 in Review

Timber Creek Capital Management reduced its Eli Lilly (LLY) stake by 0.11% in Q1 2026, selling an estimated $14.2K and leaving 12,631 shares worth $11.6M. The position accounts for 2.82% of the portfolio, ranked #12.

Timber Creek Capital Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.6M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Timber Creek Capital Management held 12,631 shares of Eli Lilly worth $11.6M as of Q1 2026.
  • Timber Creek Capital Management sold 14 Eli Lilly shares in Q1 2026, an estimated $14.2K.
  • Eli Lilly made up 2.82% of Timber Creek Capital Management's portfolio in Q1 2026, its #12 holding.
  • Timber Creek Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Timber Creek Capital Management's Eli Lilly position peaked at $13.6M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Timber Creek Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.